Group 1 - The ETF market has shown a "mixed" trend this year, with broad-based ETFs experiencing net outflows while Hong Kong-themed ETFs have gained traction, indicating a structural allocation logic in the current market [1] - Specific data shows that as of February 24, the Hang Seng Tech ETF saw a net inflow of 29.6 billion, the Hong Kong Stock Connect Internet ETF had a net inflow of 11.3 billion, the Hong Kong Stock Connect Innovative Medicine ETF recorded a net inflow of 3.015 billion, and the Hong Kong Stock Connect Tech ETF had a net inflow of 2.625 billion [1] Group 2 - Investors are increasingly focused on the investment opportunities in the Hong Kong market, with a notable interest in low valuations, sector focus, and liquidity-driven strategies [2] - The outlook for the Hong Kong market remains positive, with expectations of marginal improvements in corporate earnings and liquidity factors, which could provide a buffer against external volatility [2] - The ongoing AI technology wave is expected to continue driving growth, with a focus on technology and innovative sectors, while the supply-demand balance in the metals sector is also highlighted as a potential area of interest [2]

Group 1 - The ETF market has shown a "mixed" trend this year, with broad-based ETFs experiencing net outflows while Hong Kong-themed ETFs have gained traction, indicating a structural allocation logic in the market [1] - Specific data shows that as of February 24, the Hang Seng Tech ETF saw a net inflow of 29.6 billion, the Hong Kong Stock Connect Internet ETF had a net inflow of 11.3 billion, and the Hong Kong Stock Connect Innovative Drug ETF recorded a net inflow of 3.015 billion [1] - The overall trend reflects investors' heightened attention and inclination towards investment opportunities in the Hong Kong market, with a focus on low valuations and core assets in technology, innovative drugs, and internet platforms [2] Group 2 - The current valuation levels in the Hong Kong market are becoming increasingly attractive, with expectations of marginal improvements in corporate earnings and liquidity factors [2] - Investment strategies are focused on low-position layouts, sector concentration, and liquidity-driven approaches, with investors actively using ETFs to capture market opportunities [2] - The outlook for the Hong Kong market remains positive, with expectations of a "structural market" driven by substantial corporate earnings recovery rather than mere valuation expansion [2]

Core Viewpoint - The upcoming Chinese New Year holiday will lead to a 10-day market closure for A-shares, while Hong Kong stocks (H-shares) will continue trading, raising questions about whether H-shares can perform independently during this period. The recent adjustments in H-shares, combined with the surge in AI applications, prompt an analysis of whether the market has reached a correction point [1][3]. Market Trends - Historically, the Hang Seng Index has shown an 82% probability of rising in the three trading days before the Spring Festival, with a 40%-60% chance of increasing after the holiday. The correlation between H-shares and A-shares has strengthened, while the correlation with U.S. stocks has weakened, suggesting a potential for passive upward movement in H-shares [3]. Sector Performance - The Hang Seng Technology Index has seen significant performance metrics, with an average increase of 72.7% from Christmas to the Spring Festival. The average increase for the Hang Seng Index during the same period is 3.8% [4]. Investment Opportunities - The recent pullback in H-shares has made valuations more attractive, with expectations of a rebound. The Hang Seng Technology Index's price-to-earnings (P/E) ratio is currently at 24.5, which is below the historical average, indicating a favorable entry point for investors [7][8]. Innovation and Drug Development - Significant partnerships in the biotech sector, such as the collaboration between Innovent Biologics and Eli Lilly, highlight the potential for innovation in the pharmaceutical industry. This partnership includes a $350 million upfront payment and potential milestone payments totaling up to $8.5 billion [9]. Consumer Sector Dynamics - As the Spring Festival approaches, consumer activity is expected to rise, particularly in sectors like gold retail and hospitality. Government policies aimed at boosting consumption are likely to enhance market sentiment and drive growth in the consumer sector [11]. Dividend Strategies - In a low-interest-rate environment, dividend strategies are becoming increasingly attractive. The dividend yield for H-shares remains higher compared to A-shares, making them a compelling option for investors seeking stable returns [12][13]. Automotive Sector Growth - The automotive sector is poised for growth due to supportive policies and technological advancements in smart driving. The introduction of new policies for electric vehicle purchases is expected to stimulate demand, while advancements in autonomous driving technology present further opportunities [14][15].

Market Overview - The market temperature gauge indicates a 75% level, suggesting a strong market sentiment based on the historical P/E ratios of major indices as of February 10, 2026, with the Shanghai Composite Index at 99.59%, Shenzhen Component Index at 92.88%, and ChiNext Index at 50.6% [1]. Sector Performance - The top-performing sectors on February 10, 2026, included Media (+4.27%), Household Appliances (+2.15%), and Computer (+1.11%), while sectors like Coal (-0.84%), Social Services (-1.31%), and Real Estate (-1.40%) faced declines [2][15]. Fund Flows - The sectors with the highest net inflows were Media (¥5.341 billion), Computer (¥0.273 billion), and Social Services (¥0.209 billion). Conversely, the sectors with the largest outflows included Electric Equipment (-¥11.149 billion), Machinery (-¥4.919 billion), and Nonferrous Metals (-¥4.015 billion) [2][15]. ETF Performance - The Hong Kong Stock Connect Innovative Drug ETF (520880) rose by 2.90% on February 10, 2026, recovering above the 20-day moving average, driven by the strong performance of the innovative drug sector [5][19]. - The Sci-Tech Innovation Artificial Intelligence ETF (589520) increased by 1.81%, benefiting from the recent advancements in AI technology, particularly the release of the Seedream 5.0 model by ByteDance [7][19]. Investment Insights - Open Source Securities highlighted that China's innovative drug sector is experiencing dual breakthroughs in commercialization and internationalization, suggesting a favorable investment outlook for leading companies in this space [6][19]. - The Sci-Tech Innovation Artificial Intelligence ETF's index components have a significant collaboration with ByteDance, which holds a 29.42% weight in the index as of January 2026, indicating strong growth potential in the AI sector [7][19].

Group 1 - The core point of the article is that Innovent Biologics has entered into a strategic partnership with Eli Lilly to advance global research and development of innovative drugs in oncology and immunology, with potential financial benefits amounting to $88.5 billion [1][4]. - Innovent will receive an upfront payment of $350 million and could earn up to $8.5 billion in milestone payments, along with a share of net sales outside Greater China [1][4]. - The Hong Kong Stock Connect Innovative Drug ETF (520880) is fully invested in innovative drug R&D companies and has shown strong performance, leading its peers since 2025 [1][4]. Group 2 - The ETF's index is characterized by high purity, elasticity, and sharpness, demonstrating strong offensive capabilities in the innovative drug rebound market [1][4]. - The top ten constituent stocks of the ETF account for over 73% of its weight, indicating a concentrated representation of the core strength in innovative drug development [1][4]. - The ETF has recorded varying returns over the past five years, with a notable increase of 66.32% in one of the periods analyzed [1][4].

Group 1 - The core viewpoint of the article highlights the active performance of Hong Kong pharmaceutical stocks, particularly driven by the $8.85 billion deal from Innovent Biologics, which has led to a 5% increase in its stock price and a rise in several other stocks [1] - The total transaction scale for licensing out innovative drugs in China is projected to reach $135.7 billion by 2025, indicating a significant growth opportunity in the sector [1] - The report from Kaiyuan Securities suggests that the innovative drug sector is transitioning from "scale accumulation" to "value release," indicating a shift in market dynamics [1] Group 2 - The innovative drug sector has experienced a correction over the past two quarters, but the current valuation is considered attractive, suggesting potential investment opportunities [1] - The Hong Kong Stock Connect medical sector is also showing strength, with Xiangcai Securities stating that the pharmaceutical industry is expected to stabilize and recover [1] - The article provides information on the Hong Kong Stock Connect Innovative Drug ETF and the Huabao Medical ETF, indicating the growing interest in these investment vehicles [1]

Group 1: Market Overview - The Hong Kong pharmaceutical sector showed significant recovery on February 6, with innovative drugs experiencing a rebound, particularly the Hong Kong Stock Connect Innovative Drug ETF (520880), which rose by nearly 2% after opening in the red [1] - Notable stocks included Nocera Biopharma, which surged over 12%, projecting revenues of 2.37 billion yuan for 2025, a year-on-year increase of approximately 134%, and an expected net profit of around 630 million yuan, marking its first profit [1] Group 2: Company Performance - Rongchang Biopharma and CanSino Biologics also reported profitability, with both companies forecasting net profit growth exceeding 100% year-on-year [1] - Ark Health announced a profit forecast of 7 to 10 million yuan for 2025, indicating a turnaround from losses, and raised approximately 144.3 million HKD to accelerate the development of its AI-driven chronic disease management platform [3] - Among the 10 component stocks of the Hong Kong Stock Connect Medical ETF (159137) that disclosed earnings forecasts, 9 are expected to report profits, with several companies like Zhaoyan New Drug, MicroPort Medical, and WuXi AppTec anticipating net profit growth of over 100% [3]

Market Overview - A-shares experienced a rapid recovery on February 3, with over 4,800 stocks rising and the three major indices rebounding collectively. The Shanghai Composite Index rose by 1.29% to 4,067.74 points, while the ChiNext Index increased by 1.86%. The total market turnover was 2.57 trillion yuan, compared to 2.61 trillion yuan the previous day [1]. Sector Performance - The precious metals market saw a strong rebound, with the Color ETF (159876) recovering 6.4% and the Chemical ETF (516020) rising by 3.97%. Spot gold regained its previous day's losses, surpassing $4,900 per ounce, with multiple foreign institutions asserting that the logic behind the gold bull market remains intact [2][5]. - The military and aerospace sectors surged following the announcement of SpaceX's merger with xAI, with the Military ETF (512810) increasing by 4.75% and the General Aviation ETF (159231) rising by 3.51%. Both ETFs have over 65% exposure to commercial aerospace [3][11]. Chemical Sector Insights - The chemical sector experienced a broad-based rally, with the Chemical ETF (516020) reaching a peak increase of 4.3% during the day. Key stocks in the sector, such as Hongda Co. and Cangge Mining, saw significant gains, with some stocks rising over 9% [9]. - Analysts suggest that the recent price increases in the chemical sector are driven by a combination of supply-demand mismatches, macroeconomic easing, and industrial upgrades. The sector is expected to maintain high profitability for the next 3-5 years [7][9]. Military Sector Developments - The military sector saw a significant influx of capital, with net purchases exceeding 171 billion yuan in defense and military stocks, ranking second among 31 primary industries. The Military ETF (512810) ended a four-day decline with a strong performance, with all 80 constituent stocks rising [11][12]. - The merger of SpaceX and xAI is anticipated to enhance the valuation of domestic military enterprises involved in satellite communication and related technologies, as the market expects accelerated advancements in these areas [14]. Gold Market Analysis - Analysts from Deutsche Bank and UBS maintain a bullish outlook on gold, with predictions of prices reaching $6,000 and $4,500 as a strong support level, respectively. The demand from Chinese buyers is noted to be significantly high, potentially tripling from the previous year [6][7]. Investment Recommendations - Companies and analysts recommend maintaining a balanced exposure to the color metal sector, suggesting a portfolio allocation of 10-20% to capitalize on potential gains while mitigating risks [7]. - The chemical sector is also highlighted as a promising investment opportunity, with a focus on leading companies and those benefiting from price increases due to recent policy changes [9].

Core Insights - The cross-border ETF market in China has reached a historic milestone, with a total scale surpassing 1 trillion yuan, reaching 10,025 billion yuan in January 2023, and remaining at 9,903.82 billion yuan as of January 20, 2026 [1][2] - The market has experienced exponential growth since 2021, with the number of products increasing from 24 to 208, a growth of 7.67 times, and the total shares rising from 236.55 billion to 9,532 billion, a growth of 39.30 times [1][2] - The annual compound growth rate of cross-border ETFs has exceeded 80% since 2021, with a significant increase of 119.53% in 2025 alone [2][3] Market Dynamics - The cross-border ETF market is highly concentrated, with the top five managers (Huaxia, Fuguo, Huatai-PB, E Fund, and ICBC Credit Suisse) accounting for over 60% of the market scale [4] - The leading product in the market is the Fuguo Hong Kong Stock Internet ETF, with a scale of 894 billion yuan, followed by the Huaxia Hang Seng Technology Index ETF at approximately 524 billion yuan [4] - There are currently 25 cross-border ETFs with a scale exceeding 10 billion yuan, up from 11 at the beginning of 2025 [4] Growth Drivers - The rapid development of cross-border ETFs is driven by factors such as the accumulation of household wealth, the internationalization of the yuan, strong performance in the Hong Kong technology sector, and the trend of global capital allocation [5] - The demand for diversified asset allocation has been fueled by the limited channels for investing overseas, particularly as overseas markets, especially the US stock market, have performed well [5] - The increasing number of innovative products has lowered participation barriers, further promoting the growth of cross-border ETFs [5] Future Trends - The cross-border ETF market is expected to continue expanding, with potential growth areas including regional expansion, thematic deepening, and strategic innovation [6] - Future developments may focus on emerging markets such as Brazil, India, and Southeast Asia, as well as thematic investments in sectors like semiconductors, AI, and renewable energy [6] - The market is likely to see a shift from broad-based indices to more specialized themes, with a growing proportion of thematic ETFs [6][7]

Market Performance - The A-share market showed mixed results, with the Shanghai Composite Index rising by 0.29% and the Shenzhen Component Index increasing by 0.09%, while the ChiNext Index fell by 0.7% [1] - The total trading volume across the three major markets reached 27,321 billion yuan, a decrease of 3,243 billion yuan compared to the previous day, with over 3,500 stocks gaining [1] Sector Performance - The top-performing sectors included precious metals, electric grid equipment, chemical industry, tourism and hotels, aerospace engines, airport shipping, and paper manufacturing [1] - Conversely, sectors that experienced declines included cultural media, AI mobile phones, computing power leasing, brain-computer interfaces, banking, and weight loss drugs [1] ETF Highlights - The electric grid concept ETFs saw significant gains, with Huaxia Fund's electric grid equipment ETF rising by 7.76%, Guotai Fund's electric grid ETF increasing by 7.18%, and GF Fund's electric grid ETF also up by 7.18% [1] - The photovoltaic sector performed well, with the leading photovoltaic ETF from GF rising by 5.16% [1] - The commercial aerospace sector rebounded, with Haitai Baichuan Fund's aerospace ETF and Wanjia Fund's aerospace ETF increasing by 5.16% and 3.76%, respectively [1] - The tourism sector also saw gains, with Fuguo Fund's tourism ETF and Huaxia Fund's tourism ETF rising by 4.43% and 4.37%, respectively [1] - The chemical sector was active, with the E Fund's chemical industry ETF increasing by 3.51% [1] Declining ETFs - The Sci-Tech 100 ETF enhanced index fund fell by 5% [2] - The semiconductor sector declined, with the Sci-Tech semiconductor ETF from Penghua dropping by 3.67% [2] - The Hong Kong stock innovation drug sector also saw a decline, with the Hong Kong Stock Connect innovation drug ETF falling by 3.24% [2]